FPOC
TMO icon

Financial Planners of Cleveland’s Thermo Fisher Scientific TMO Stock Holding History

Financial Planners of Cleveland’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-354
Closed -$209K – 46
2022
Q1 		$209K Sell
354
-35
-9% -$20.1K 0.09% 53
2021
Q4 		$234K Buy
+389
New +$243K 0.1% 78

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Planners of Cleveland's TMO Position: Q2 2022 in Review

Financial Planners of Cleveland sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 354 shares — an estimated $209K sold.

Financial Planners of Cleveland first reported a position in TMO in Q4 2021 and held it in 2 quarters. The position peaked at $234K in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Financial Planners of Cleveland reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Financial Planners of Cleveland sold 354 Thermo Fisher Scientific shares in Q2 2022, an estimated $209K.
  • Financial Planners of Cleveland first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 2 quarters.
  • Financial Planners of Cleveland's Thermo Fisher Scientific position peaked at $234K in Q4 2021.
  • 2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Financial Planners of Cleveland's 13F filing for Q2 2022.